# Xingmeng Yang

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/xingmeng-yang/

## Facts

| Field | Value |
| --- | --- |
| Citations | 20 |
| Field | Heart Failure Treatment and Management |
| h-index | 2 |
| i10-index | 1 |
| Last Known Institution | Cangzhou Central Hospital |
| OpenAlex ID | https://openalex.org/A5011328881 |
| Works | 3 |

## Researcher papers

- [Study on the Efficacy of Sacubitril/Valsartan in Patients with Heart Failure with Preserved Ejection Fraction Undergoing Peritoneal Dialysis](https://scholariq.org/papers/study-on-the-efficacy-of-sacubitril-valsartan-in-patients-with-heart-failure/)
- [aveExpression of mir-29a-5p, sclerostin and fetuin-A in patients with chronic kidney disease and their correlation with vascular calcification](https://scholariq.org/papers/aveexpression-of-mir-29a-5p-sclerostin-and-fetuin-a-in-patients-with-chronic/)
- [Expression profiles of miR-129 and miR-29a-5p in vascular calcification of patients with end-stage renal disease and the underlying correlation](https://scholariq.org/papers/expression-profiles-of-mir-129-and-mir-29a-5p-in-vascular-calcification-of/)

## Researcher topics

- [Heart Failure Treatment and Management](https://scholariq.org/topics/heart-failure-treatment-and-management/)
- [Dialysis and Renal Disease Management](https://scholariq.org/topics/dialysis-and-renal-disease-management/)
- [Parathyroid Disorders and Treatments](https://scholariq.org/topics/parathyroid-disorders-and-treatments/)
- [Cardiovascular Function and Risk Factors](https://scholariq.org/topics/cardiovascular-function-and-risk-factors/)
- [Bone Metabolism and Diseases](https://scholariq.org/topics/bone-metabolism-and-diseases/)

## Researcher university

- [Cangzhou Central Hospital](https://scholariq.org/institutions/cangzhou-central-hospital/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.